These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 12496718)

  • 21. [Multicenter, double-blind study comparing rilmenidine 1 mg and hydrochlorothiazide 25 mg in 244 patients].
    Fiorentini C; Guillet C; Guazzi M
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():39-46. PubMed ID: 2517008
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Antihypertensive efficacy and acceptability of rilmenidine in elderly hypertensive patients.
    Galley P; Manciet G; Hessel JL; Michel JP
    Am J Cardiol; 1988 Feb; 61(7):86D-90D. PubMed ID: 2894166
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of rilmenidine on 24-h rhythmicity of blood pressure and spontaneous baroreflex sensitivity in essential hypertensive subjects.
    Finta E; Laude D; Alföldi S; Farsang C; Elghozi JL
    J Hypertens; 2006 Aug; 24(8):1619-25. PubMed ID: 16877965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A multicenter double-blind comparative study of rilmenidine and clonidine in 333 hypertensive patients.
    Fillastre JP; Letac B; Galinier F; Le Bihan G; Schwartz J
    Am J Cardiol; 1988 Feb; 61(7):81D-85D. PubMed ID: 2894165
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Shifting trends in the pharmacologic treatment of hypertension in a Nigerian tertiary hospital: a real-world evaluation of the efficacy, safety, rationality and pharmaco-economics of old and newer antihypertensive drugs.
    Adigun AQ; Ishola DA; Akintomide AO; Ajayi AA
    J Hum Hypertens; 2003 Apr; 17(4):277-85. PubMed ID: 12714973
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chronic treatment with rilmenidine in spontaneously hypertensive rats: differences between two schedules of administration.
    Monassier L; Greney H; Thomas L; Bousquet P
    J Cardiovasc Pharmacol; 2004 Mar; 43(3):394-401. PubMed ID: 15076223
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of rilmenidine, a selective I1 imidazoline receptor binding agent in diabetic hypertensive patients.
    Dupuy O; Bauduceau B; Mayaudon H
    Am J Hypertens; 2000 Jun; 13(6 Pt 2):123S-126S. PubMed ID: 10921531
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative effects of rilmenidine and atenolol on tests of autonomic function and mental and dynamic exercise in patients with essential hypertension.
    Panfilov V; Morris AD; Donnelly R; Reid JL
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S44-7. PubMed ID: 8642805
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of rilmenidine for arterial hypertension.
    Beau B; Mahieux F; Paraire M; Laurin S; Brisgand B; Vitou P
    Am J Cardiol; 1988 Feb; 61(7):95D-102D. PubMed ID: 2894168
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Efficacy and acceptability of rilmenidine in mild to moderate arterial hypertension. A multicenter, randomized, double-blind trial, in comparison with methyldopa in 157 patients].
    Wilkinson R; Mansy S; Corcoran C
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():31-8. PubMed ID: 2517007
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Effects of rilmenidine on the central nervous system and kidney].
    Fillastre JP
    Arch Mal Coeur Vaiss; 1989 Dec; 82 Spec No 5():19-23. PubMed ID: 2517005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Blockade of sympathetic nervous system activity by rilmenidine increases plasma adiponectin concentration in patients with essential hypertension.
    Nowak Ł; Adamczak M; Wiecek A
    Am J Hypertens; 2005 Nov; 18(11):1470-5. PubMed ID: 16280284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of three months' treatment with irbesartan on blood and pulse pressure of hypertensive type 2 diabetic patients: open, observational study in 31,793 patients.
    Strutz F; Bramlage P; Paar WD
    Curr Med Res Opin; 2005 Sep; 21(9):1433-40. PubMed ID: 16197662
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How can we block sympathetic overactivity? Effects of rilmenidine and atenolol in overweight hypertensive patients.
    Konrady AO; Kasherininov YR; Shavarov AA; Shavarova EK; Vachrameeva NV; Krutikov AN; Smirnova EV; Shlyakhto EV
    J Hum Hypertens; 2006 Jun; 20(6):398-406. PubMed ID: 16543910
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Lipid profile and antihypertensive efficacy in hyperlipidemic hypertensive patients: comparison of rilmenidine and captopril.
    Scemama M; Février B; Beucler I; Dairou F
    J Cardiovasc Pharmacol; 1995; 26 Suppl 2():S34-9. PubMed ID: 8642803
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy and acceptability of rilmenidine for mild to moderate systemic hypertension.
    Ostermann G; Brisgand B; Schmitt J; Fillastre JP
    Am J Cardiol; 1988 Feb; 61(7):76D-80D. PubMed ID: 2894164
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of two centrally-acting anti-hypertensive drugs on the quality of life.
    Fletcher AE; Beevers DG; Dollery CT; Wilkinson R; Bulpitt CJ
    Eur J Clin Pharmacol; 1991; 41(5):397-400. PubMed ID: 1684749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Update on rilmenidine: clinical benefits.
    Reid JL
    Am J Hypertens; 2001 Nov; 14(11 Pt 2):322S-324S. PubMed ID: 11721891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Rilmenidine sympatholytic activity preserves mental and orthostatic sympathetic response and epinephrine secretion].
    Esler M; Lux A; Jennings G; Hastings J; Socratous F; Lambert G
    Arch Mal Coeur Vaiss; 2004; 97(7-8):786-92. PubMed ID: 15506067
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The chronic effect of rilmenidine on heart rate variability in patients with mild hypertension.
    Eryonucu B; Ulgen MS; Bilge M; Güler N; Güneş A
    Angiology; 2002; 53(2):199-204. PubMed ID: 11952111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.